Skip to main navigation Skip to search Skip to main content

Low prevalence of late-onset neutropenia after rituximab treatment in patients with pemphigus

Katharina Boch*, Detlef Zillikens, Ewan A. Langan, Enno Schmidt, Ralf J. Ludwig

*Corresponding author for this work
Original languageEnglish
JournalJournal of the American Academy of Dermatology
Volume83
Issue number6
Pages (from-to)1824-1825
Number of pages2
ISSN0190-9622
DOIs
Publication statusPublished - 12.2020

Funding

Funding sources: Excellence Cluster “Precision Medicine in Chronic Inflammation” (EXC 2167) from the Deutsche Forschungsgemeinschaft .

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Research Areas and Centers

  • Academic Focus: Center for Infection and Inflammation Research (ZIEL)

Cite this